Product Information

AMLODIPINE-OLMESARTAN 5-20 MG is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2476 per EA under NDC 62332021290. Its NADAC has been published 103 times since Jul 10, 2024.

AMLODIPINE-OLMESARTAN 5-20 MG

Amlodipine besylate and Olmesartran medoxomil
$0.2476per EA

Strength

5; 20 mg/1; mg/1

NDC

62332021290

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207073

On Market Since

7/18/2017

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has been published 103 times since Jul 10, 2024, and over the history we have for it it has declined 17.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2476 per EA
All-time high$0.3380 (Nov 13, 2024)
All-time low$0.2347 (Apr 22, 2026)
52-week high$0.3120
52-week low$0.2347
Median price$0.2860
Average price$0.2771
Largest weekly change+41.4% (Aug 21, 2024)
Weeks tracked103
Tracking sinceJul 10, 2024

Price History

1W

0.0%

1M

+2.2%

3M

+3.2%

6M

+4.7%

1Y

-20.6%

3Y

N/A

5Y

N/A

All

-17.3%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 5-20 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-20 MG, manufactured by Alembic Pharmaceuticals Inc., is $0.2476 per EA (NDC 62332021290), effective Jun 24, 2026.

How has the price of AMLODIPINE-OLMESARTAN 5-20 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has declined 17.3%. It has been tracked across 103 weekly CMS publications since Jul 10, 2024.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-20 MG?

Since Jul 10, 2024, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has ranged from a low of $0.2347 (Apr 22, 2026) to a high of $0.3380 (Nov 13, 2024), with a median of $0.2860 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-20 MG?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as AMLODIPINE-OLMESARTAN 5-20 MG, but none are currently priced below it.

Who manufactures AMLODIPINE-OLMESARTAN 5-20 MG?

AMLODIPINE-OLMESARTAN 5-20 MG (NDC 62332021290) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.